Correlation Between Beta Drugs and Kilitch Drugs

Can any of the company-specific risk be diversified away by investing in both Beta Drugs and Kilitch Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beta Drugs and Kilitch Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Beta Drugs and Kilitch Drugs Limited, you can compare the effects of market volatilities on Beta Drugs and Kilitch Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beta Drugs with a short position of Kilitch Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beta Drugs and Kilitch Drugs.

Diversification Opportunities for Beta Drugs and Kilitch Drugs

-0.51

Correlation Coefficient

Beta Drugs  Kilitch Drugs

Excellent diversification

The 3 months correlation between Beta and Kilitch is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Beta Drugs and Kilitch Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kilitch Drugs Limited and Beta Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beta Drugs are associated (or correlated) with Kilitch Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kilitch Drugs Limited has no effect on the direction of Beta Drugs i.e., Beta Drugs and Kilitch Drugs go up and down completely randomly.

Pair Corralation between Beta Drugs and Kilitch Drugs

Assuming the 90 days trading horizon Beta Drugs is expected to generate 1.27 times more return on investment than Kilitch Drugs. However, Beta Drugs is 1.27 times more volatile than Kilitch Drugs Limited. It trades about 0.12 of its potential returns per unit of risk. Kilitch Drugs Limited is currently generating about -0.02 per unit of risk. If you would invest  176,250  in Beta Drugs on September 4, 2024 and sell it today you would earn a total of  43,750  from holding Beta Drugs or generate 24.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.41%
Values	Daily Returns

Beta Drugs  vs.  Kilitch Drugs Limited

Beta Drugs

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Beta Drugs unveiled solid returns over the last few months and may actually be approaching a breakup point.

Kilitch Drugs Limited

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kilitch Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Kilitch Drugs is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Beta Drugs and Kilitch Drugs

The main advantage of trading using opposite Beta Drugs and Kilitch Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beta Drugs position performs unexpectedly, Kilitch Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kilitch Drugs will offset losses from the drop in Kilitch Drugs' long position.

The idea behind Beta Drugs and Kilitch Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.